Solbinsiran (sodium)
Solbinsiran sodium is a siRNA targeted to hepatic ANGPTL3.
Product Specifications
CAS Number
2707429-60-3
Product Name Alternative
LY3561774 sodium
UNSPSC
12352208
Target
ANGPTL
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Smiles
[Solbinsiran(sodium)]
Molecular Formula
HD
Molecular Weight
3.02
References & Citations
[1]Ray KK, Oru E, Rosenson RS, et al. Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeted to ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3) : a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet. 2025;405 (10489) :1594-1607.|[2]Ray KK, Linnebjerg H, Michael LF, et al. Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies. J Am Coll Cardiol. 2025;85 (19) :1803-1818.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GA-E0962MS-01 48 Tests
Mouse dihydropyrimidinase-like 2 (DPYSL2) ELISA Kit
Sign In for Pricing
View Details GA-E0962MS-02 96 Tests
Mouse dihydropyrimidinase-like 2 (DPYSL2) ELISA Kit
Sign In for Pricing
View Details 
bs-7520R-APC-Cy7 100 µL
SPON1 Polyclonal Antibody, APC-Cy7 Conjugated
Sign In for Pricing
View Details TMB31149-01 50 mg
5,10,12-Trioxa-4-boratricyclo[7.3.0.0,3,7]dodeca-1 (9),2,7-trien-4-ol
Sign In for Pricing
View Details